Listed by the USPTO as BAEK, BONG-SOOK
Tech Center 1600 • Art Units: 1611 1614 1619 1621 1624 1627 1629 1693
This examiner grants 42% of resolved cases
BAEK, BONG-SOOK is a USPTO patent examiner in tech center 1600 and art unit 1611. The examiner has 925 resolved cases, an allowance rate of 41.6%, and a median of 1141 days to allowance. Interviews are associated with a 69.9% lift.
The recurring companies are Scai Therapeutics Co. Ltd., Beam Therapeutics Inc., and Boehringer Ingelheim International GmbH. The leading firms are SUGHRUE MION, PLLC, Acuity Law Group, P.C., and AKERMAN LLP. The interview result is a central feature of this profile for practitioners considering examiner engagement, while the allowance rate and median timing inform claim strategy, response sequencing, and portfolio planning.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18801886 | Cardiosafe Antidiabetic Therapy | Final Rejection | Boehringer Ingelheim International GmbH |
| 18012099 | AMELIORATING AGENT OR PROPHYLACTIC AGENT FOR MUSCLE WEAKNESS SYMPTOM IN DISEASE OR SYNDROME ASSOCIATED WITH METABOLIC DISORDER | Non-Final OA | Toray Industries, Inc. |
| 18741056 | MULTICOMPONENT DEGRADABLE CATIONIC POLYMERS | Non-Final OA | The Johns Hopkins University |
| 18907757 | COMBINATIONS COMPRISING BREXPIPRAZOLE OR A SALT THEREOF AND A SECOND DRUG FOR USE IN THE TREATMENT OF A CNS DISORDER | Non-Final OA | OTSUKA PHARMACEUTICAL CO., LTD. |
| 19048181 | METHODS OF TREATING MULTIPLE SCLEROSIS | Non-Final OA | Biogen MA Inc. |
| 18401379 | PROPHYLAXIS AND THERAPY FOR VASCULAR COMPLICATIONS OF DIABETES WITH IMMUNE BOOSTING | Non-Final OA | Individual inventor |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy41.6% of resolved applications examined by Bong-Sook Baek were allowed (925 resolved cases), compared with 35.0% across Art Unit 1611 over the last five years.
This examiner's interview lift is +69.9 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Bong-Sook Baek took 1,141 days on average from filing to allowance.
Bong-Sook Baek examines applications in Art Unit 1611 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
